Terminology Service < Semantic Lookup Platform

All terms in CHEBI

Label	Id	Description
(-)-syringaresinol	CHEBI_49212	[The (7beta,7'beta,8beta,8'beta)-stereoisomer of syringaresinol.]
(+)-syringaresinol	CHEBI_47	[The (7alpha,7'alpha,8alpha,8'alpha)-stereoisomer of syringaresinol.]
(S)-beta-himachalene	CHEBI_49213
(R)-beta-himachalene	CHEBI_49208	[The (R)-enantiomer of beta-himachalene.]
CHEBI_40877	CHEBI_40877
alpha-himachalene	CHEBI_49214
galloyl alpha-D-glucose	CHEBI_49215
cis-alpha-himachalene	CHEBI_49216
N-methyl-N(alpha)-[(5-sulfanyl-1,3,4-thiadiazol-2-yl)carbamoyl]-L-phenylalaninamide	CHEBI_40873
(1R,6S)-alpha-himachalene	CHEBI_49218	[The (1R,6S)-stereoisomer of cis-alpha-himachalene.]
(1S,6R)-alpha-himachalene	CHEBI_49219
[2-(3-dibenzo[b,d]furan-4-ylphenyl)-1-hydroxyethane-1,1-diyl]bis(phosphonic acid)	CHEBI_40875
C15-(R)-METHYLTHIENYL RAPAMYCIN	CHEBI_40870
macrolide lactam	CHEBI_145565	[A macrolide in which the macrocyclic lactone ring includes an amide group.]
CHEBI_40872	CHEBI_40872
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor	CHEBI_49200	[An EC 3.6.3.* (acid anhydride hydrolase catalysing transmembrane movement of substances) inhibitor that inhibits H(+)/K(+)-exchanging ATPase, EC 3.6.3.10. Such compounds are also known as proton pump inhibitors.]
elemental platinum	CHEBI_49202
platinum molecular entity	CHEBI_33749
torcetrapib	CHEBI_49203
CETP inhibitor	CHEBI_49205	[Any inhibitor of cholesterylester transfer protein (CETP), which transfers cholesterol from high density lipoproteins (HDL, the 'good' cholesterol-containing particles) to low or very low density lipoproteins (LDL or VLDL, the 'bad' cholesterol-containing particles). Inhibition of this process results in higher HDL levels and lower LDL levels. CETP inhibitors are under investigation as potential drugs to reduce the risk of arteriosclerotic vascular disease (atherosclerosis).]